PubRank

D M Wieland

Author PubWeight™ 62.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Scintigraphic localization of pheochromocytoma. N Engl J Med 1981 1.88
2 Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 1990 1.78
3 Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med 1980 1.62
4 Iodine-125-MIBG to treat neuroblastoma: preliminary report. J Nucl Med 1990 1.48
5 In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol 1996 1.45
6 Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981 1.31
7 Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation 1998 1.29
8 Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 1981 1.21
9 Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987 1.18
10 Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. Mol Pharmacol 1984 1.15
11 Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nucl Med 1990 1.07
12 Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine. Ann Intern Med 1981 1.06
13 Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. Am J Physiol Imaging 1986 1.03
14 Assessment of cardiac sympathetic nerve integrity with positron emission tomography. Nucl Med Biol 2001 1.01
15 Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism 1999 1.01
16 Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication. J Nucl Med 1981 0.98
17 Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987 0.98
18 [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses. Synapse 1998 0.98
19 PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol 1989 0.97
20 PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med 1992 0.97
21 Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol 1993 0.97
22 Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol 1998 0.96
23 Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med 1985 0.94
24 Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 1993 0.89
25 In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J Nucl Med 1994 0.89
26 Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience. J Nucl Biol Med 1992 0.89
27 Evaluation of sympathetic nerve terminals with [(11)C]epinephrine and [(11)C]hydroxyephedrine and positron emission tomography. Circulation 2000 0.88
28 Myocardial kinetics of carbon-11-meta-hydroxyephedrine: retention mechanisms and effects of norepinephrine. J Nucl Med 1993 0.88
29 Mouse brain distribution of a carbon-11 labeled vesamicol derivative: presynaptic marker of cholinergic neurons. Life Sci 1990 0.86
30 In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography. J Cereb Blood Flow Metab 1992 0.85
31 High yield synthesis of high specific activity R-(-)-[11C]epinephrine for routine PET studies in humans. Nucl Med Biol 1993 0.85
32 Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol. J Med Chem 1996 0.84
33 Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication. J Nucl Med 1984 0.84
34 Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma. J Nucl Biol Med 1992 0.83
35 Synthesis and preliminary evaluation of [11C]-(-)-phenylephrine as a functional heart neuronal PET agent. Nucl Med Biol 1996 0.82
36 Synthesis of the 123I- and 125I-labeled cholinergic nerve marker (-)-5-iodobenzovesamicol. Nucl Med Biol 1993 0.82
37 Synthesis and in vivo evaluation of a 99m/99Tc-DADT-benzovesamicol: a potential marker for cholinergic neurons. Nucl Med Biol 1994 0.82
38 Synthesis and evaluation of [123I]-iodo-PK11195 for mapping peripheral-type benzodiazepine receptors (omega 3) in heart. Nucl Med Biol 1996 0.81
39 Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine. J Nucl Med 1986 0.80
40 Myocardial kinetics of carbon-11-epinephrine in the isolated working rat heart. J Nucl Med 1997 0.80
41 Synthesis of a high specific activity 125I-labeled analog of PK 11195, potential agent for SPECT imaging of the peripheral benzodiazepine binding site. Int J Rad Appl Instrum B 1989 0.80
42 Clinical evaluation of carbon-11-phenylephrine: MAO-sensitive marker of cardiac sympathetic neurons. J Nucl Med 1996 0.80
43 Adrenal medulla imaging agents: a structure-distribution relationship study of radiolabeled aralkylguanidines. J Med Chem 1984 0.80
44 Adrenal imaging agents: rationale, synthesis, formulation and, metabolism. Semin Nucl Med 1978 0.79
45 Development of a kit-form analog of metaiodobenzylguanidine. J Nucl Med 1986 0.79
46 Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent. J Nucl Med 1979 0.79
47 Metaiodobenzylguanidine [131I] scintigraphy detects impaired myocardial sympathetic neuronal transport function of canine mechanical-overload heart failure. Circ Res 1987 0.79
48 Sensitivity of [11C]phenylephrine kinetics to monoamine oxidase activity in normal human heart. J Nucl Med 1999 0.79
49 Evaluation of (-)[18F]fluoroethoxybenzovesamicol as a new PET tracer of cholinergic neurons of the heart. Nucl Med Biol 1994 0.79
50 Treatment of neuroblastoma with [125I]metaiodobenzylguanidine. J Nucl Biol Med 1992 0.79
51 Assessment of myocardial reinnervation in cardiac transplants by positron emission tomography: functional significance tested by heart rate variability. Clin Sci (Lond) 1996 0.79
52 Influence of vesicular storage and monoamine oxidase activity on [11C]phenylephrine kinetics: studies in isolated rat heart. J Nucl Med 1999 0.78
53 Development of nonionic gamma-emitting radiopharmaceuticals for myocardial imaging. J Nucl Med 1978 0.78
54 Synthesis of 11C-labeled desipramine and its metabolite 2-hydroxydesipramine: potential radiotracers for PET studies of the norepinephrine transporter. Nucl Med Biol 1997 0.78
55 Effect of regional myocardial ischemia on sympathetic nervous system as assessed by fluorine-18-metaraminol. J Nucl Med 1990 0.78
56 PET hydroxyephedrine imaging of neuroblastoma. J Nucl Med 1996 0.77
57 Radioiodinated fatty acids for myocardial imagine: effects on chain length. J Nucl Med 1981 0.77
58 Fluorine for hydroxy substitution in biogenic amines: asymmetric synthesis and biological evaluation of fluorine-18-labeled beta-fluorophenylalkylamines as model systems. J Med Chem 1995 0.77
59 Scintigraphic detection of regional disruption of adrenergic neurons in the heart. Am Heart J 1988 0.77
60 A radiotracer for mapping cholinergic neurons of the brain. J Med Chem 1990 0.77
61 Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine. Eur J Nucl Med 1988 0.77
62 Imaging of cardiac neuronal function after cocaine exposure using carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 1994 0.77
63 Imaging of monoaminergic and cholinergic vesicular transporters in the brain. Adv Pharmacol 1998 0.76
64 Direct optical resolution of vesamicol and a series of benzovesamicol analogues by high-performance liquid chromatography. J Chromatogr A 1994 0.76
65 Radioiodinated benzodiazepines: agents for mapping glial tumors. J Med Chem 1988 0.76
66 Synthesis of carbon-11-, fluorine-18-, and iodine-125-labeled GABAA-gated chloride ion channel blockers: substituted 5-tert-butyl-2-phenyl-1,3-dithianes and -dithiane oxides. J Med Chem 1995 0.76
67 PD 90780, a non peptide inhibitor of nerve growth factor's binding to the P75 NGF receptor. Biochem Biophys Res Commun 1995 0.76
68 Metabolic fate of the heart agent [18F]6-fluorometaraminol. Int J Rad Appl Instrum B 1989 0.76
69 6-[18F]fluorometaraminol: a radiotracer for in vivo mapping of adrenergic nerves of the heart. J Med Chem 1988 0.75
70 Localization of radiolabeled enzyme inhibitors in the adrenal gland. J Nucl Med 1976 0.75
71 Adrenal cortical 11 beta-hydroxylase and side-chain cleavage enzymes. Requirement for the A- or B-pyridyl ring in metyrapone for inhibition. J Steroid Biochem 1985 0.75
72 Imaging the adrenal glands with radiolabeled inhibitors of enzymes: concise communication. J Nucl Med 1978 0.75
73 Iodine-125 and fluorine-18 labeled aryl-1,4-dialkylpiperazines: potential radiopharmaceuticals for in vivo study of the dopamine uptake system. Int J Rad Appl Instrum A 1992 0.75
74 Effects of active chronic cocaine use on cardiac sympathetic neuronal function assessed by carbon-11-hydroxyephedrine. J Nucl Med 1997 0.75
75 Mechanism-based strategies for mapping heart sympathetic nerve function. Nucl Med Biol 1995 0.75
76 Development of a tomographic myelin scan. Ann Neurol 1981 0.75
77 The purity of 19-iodocholesterol and 6 beta-iodomethylnorcholesterol. Semin Nucl Med 1978 0.75
78 Pituitary localization of 3H-spiroperidol by an uptake/storage mechanism? Int J Rad Appl Instrum B 1986 0.75
79 A rapid high yield synthesis of no-carrier-added (-)-[123I]iodocyanopindolol. Int J Rad Appl Instrum A 1991 0.75
80 Portrayal of adrenergic denervation in the presence of myocardial infarction: a feasibility study. Am J Physiol Imaging 1990 0.75
81 Radiolabeled meta-iodobenzylguanidine and the adrenergic neurons of salivary glands. Am J Physiol Imaging 1987 0.75
82 Structure-activity relationship study of the inhibition of adrenal cortical 11 beta-hydroxylase by new metyrapone analogues. J Med Chem 1984 0.75
83 omega-Iodophenyl fatty acids: a convenient method of radioiodination. Int J Rad Appl Instrum A 1986 0.75
84 Synthesis and receptor binding studies of (+/-)1-iodo-MK-801. Pharm Res 1989 0.75
85 Scintigraphic portrayal of beta receptors in the heart. J Nucl Med 1991 0.75
86 Anatomy and physiology as a predictor of success in baccalaureate nursing students. J Nurs Educ 1995 0.75
87 Concentration of dopamine analogs in the adrenal medulla. J Nucl Med 1975 0.75
88 Use of DES-treated rats as an animal model for assessment of pituitary adenoma imaging agents. Int J Rad Appl Instrum B 1986 0.75